HSPG2 and neoplasm: They observed a reduction in PLCε expression in human lung adenocarcinomas and colorectal and skin tumors and Ras-driven animal tumors, indicating the role of this PLC as a tumor suppressor and suggesting its use as a biological marker in cancer.